Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

v3.22.4
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Dec. 31, 2022
Mar. 31, 2022
Current assets    
Cash $ 17,499,541 $ 17,072,419
Accounts receivable 0 127,965
Prepaid expenses and other current assets 672,781 956,623
Total current assets 18,172,322 18,157,007
Property and equipment, net 1,212,120 441,238
Right-of-use lease asset 1,217,458 696,698
Patents, net 1,788 2,200
Restricted cash 87,506 87,506
Deposits 33,305 33,305
Total assets 20,724,499 19,417,954
Current liabilities    
Accounts payable 226,791 499,962
Due to related parties 190,397 155,742
Deferred revenue 574,245 344,547
Lease liability, current portion 264,278 126,905
Other current liabilities 1,180,312 696,893
Total current liabilities 2,436,023 1,824,049
Lease liability, less current portion 1,009,277 602,505
Total liabilities 3,445,300 2,426,554
Stockholders’ Equity    
Common stock, par value $0.001 per share; 60,000,000 and 30,000,000 shares authorized as of December 31, 2022 and March 31, 2022, respectively; 22,969,349 and 15,419,163 shares issued and outstanding as of December 31, 2022 and March 31, 2022, respectively 22,971 15,421
Additional paid-in capital 157,148,260 147,446,868
Accumulated deficit (139,892,032) (130,329,181)
Total Aethlon Medical, Inc. stockholders’ equity before noncontrolling interests 17,279,199 17,133,108
Noncontrolling interests 0 (141,708)
Total stockholders’ equity 17,279,199 16,991,400
Total liabilities and stockholders’ equity $ 20,724,499 $ 19,417,954